98%
921
2 minutes
20
Background: Extracorporeal cardiopulmonary resuscitation (ECPR) is a potential intervention for refractory in-hospital cardiac arrest (IHCA). This study aimed to evaluate the outcomes of ECPR in patients with refractory IHCA at a university-affiliated tertiary care center.
Methods: We performed a retrospective, observational analysis of an institutional database of adult patients who received ECPR for refractory IHCA from January 2007 to December 2023. The primary endpoint was survival to hospital discharge with a favorable neurological outcome, defined as a Cerebral Performance Category (CPC) score of 1 or 2. Patients with a CPC score of 1-2 were compared to those with a CPC score ≥ 3.
Results: During the study period, 147 patients received ECPR for refractory IHCA (mean age 51.0 years, 64.6% male). Baseline characteristics were comparable between both groups. Mean no-flow time and low-flow time and the rate of shockable rhythms were comparable between both groups. Eighty-nine (60.5%) patients died during temporary mechanical circulatory support. Among the 56 (38.1%) patients who were weaned from mechanical circulatory support, 24 (16.3%) died before hospital discharge. The overall survival to discharge was 22.4%, with 20.4% achieving a CPC score of 1-2.
Conclusions: Owing to the invariably fatal nature of refractory IHCA, ECPR offered a reasonable survival with a favorable neurological outcome in this critically ill patients' population.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/aor.15028 | DOI Listing |
J Clin Med
July 2025
Department of Anesthesiology and Perioperative Medicine, Medical University of South Carolina, Charleston, SC 29425, USA.
Extracorporeal cardiopulmonary resuscitation (ECPR) is an established intervention for select patients experiencing refractory cardiac arrest. Among modifiable predictors of survival and neurologic recovery during ECPR implementation, timely restoration of circulation remains critical in the setting of refractory cardiac arrest (CA). The in-hospital cardiac arrest (IHCA) setting is particularly amenable to reducing the low-flow interval through structured system-based design and implementation.
View Article and Find Full Text PDFTurk J Emerg Med
July 2025
Department of Critical Care, East Slovak Institute for Cardiovascular Diseases, Košice, Slovakia.
Extracorporeal cardiopulmonary resuscitation is being increasingly used to treat refractory in-hospital cardiac arrest (IHCA). Etiologies of IHCA may differ from etiologies of out-of-hospital cardiac arrest. We report a case of a 50-year-old man who was admitted to a local hospital, presenting with drowsiness, hypotension, and severe metabolic acidosis.
View Article and Find Full Text PDFResusc Plus
July 2025
Department of Cardiothoracic Surgery, University Medical Center Regensburg, Franz-Josef-Strauß-Allee 11, Regensburg 93053, Germany.
Background: Extracorporeal life support (ECLS) is increasingly employed for severe respiratory or cardiac failure, alongside a rising adoption of extracorporeal cardiopulmonary resuscitation (eCPR). Despite increased adoption, limited evidence underscores possible cytokines' pivotal role in the inflammatory response during ECLS.
Methods: The study involved 546 eCPR patients using veno-arterial extracorporeal membrane oxygenation from 2013 to 2023.
Artif Organs
May 2025
Department of Cardiac Surgery, Louis Pradel Hospital, Hospices Civils de Lyon, Lyon, France.
Background: Extracorporeal cardiopulmonary resuscitation (ECPR) is a potential intervention for refractory in-hospital cardiac arrest (IHCA). This study aimed to evaluate the outcomes of ECPR in patients with refractory IHCA at a university-affiliated tertiary care center.
Methods: We performed a retrospective, observational analysis of an institutional database of adult patients who received ECPR for refractory IHCA from January 2007 to December 2023.
Medicina (Kaunas)
September 2024
2nd Department of Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital, 12 808 Prague, Czech Republic.